Ben Tre Pharmaceutical JSC Capital Reinvestment Ratio
Latest as of June 2020:
0.00x
Ben Tre Pharmaceutical JSC capital reinvestment ratio. Ben Tre Pharmaceutical JSC (DBT) has a Capital Reinvestment Ratio of 0.00x as of June 2020, meaning it reinvests 0% of its operating cash flow (₫37.04 Billion) in capital expenditures (₫87.53 Million).
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
₫37.04 Billion
VND
Capital Expenditures
₫87.53 Million
VND
Data as of
Jun 2020
Most recent filing
Capital Reinvestment Ratio of Ben Tre Pharmaceutical JSC (2016–2017)
Capital reinvestment ratio of Ben Tre Pharmaceutical JSC from 2016 to 2017. This chart tracks Ben Tre Pharmaceutical JSC's Capital Reinvestment Ratio across 2 annual periods.
Ben Tre Pharmaceutical JSC Capital Reinvestment Ratio by Year (2016–2017)
Ben Tre Pharmaceutical JSC capital reinvestment ratio by year from 2016 to 2017.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.18x | ₫51.07 Billion | ₫9.02 Billion | ▲ +28.4% |
| 2016 | 0.14x | ₫32.71 Billion | ₫4.50 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow